Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
International Immunopharmacology (2021) - Comments
pubmed: 34273635  doi: 10.1016/j.intimp.2021.107969  issn: 1567-5769  issn: 1878-1705 

Ilad Alavi Darazam, Shervin Shokouhi, Masoud Mardani, Mohamad Amin Pourhoseingholi, Mohammad Mahdi Rabiei, Firouze Hatami, Minoosh Shabani, Omid Moradi, Farid Javandoust Gharehbagh, Seyed Sina Naghibi Irvani, Mahdi Amirdosara, Mohammadreza Hajiesmaeili, Omidvar Rezaei, Ali Khoshkar, Legha Lotfollahi, Latif Gachkar, Hadiseh Shabanpour Dehbsneh, Negar Khalili, Azam Soleymaninia, Akram Hoseyni Kusha